US FDA approves Lilly and Incyte’s Olumiant for treating certain hospitalised patients with… EP News Bureau May 13, 2022 Olumiant is the first and only FDA-approved JAK inhibitor for the treatment of COVID-19 in certain hospitalised adults requiring…
US FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly Reuters Dec 6, 2021 The US Food and Drug Administration's boxed warnings on the labels of Rinvoq , Xeljanz and Olumiant flags the risk of…
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:… EP News Bureau Sep 15, 2020 Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
